BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38371643)

  • 1. The histological prevalence of prostatitis at Potchefstroom Hospital: a cross-sectional study.
    Prince Kasongo M; Philippa E; Fabienne WH; Marylyne Y; Behnazir M
    Pan Afr Med J; 2024; 47():8. PubMed ID: 38371643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
    Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
    S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
    Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
    Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy.
    De Luca S; Passera R; Fiori C; Bollito E; Cappia S; Mario Scarpa R; Sottile A; Franco Randone D; Porpiglia F
    Urol Oncol; 2015 Oct; 33(10):424.e17-23. PubMed ID: 26162485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum prostate-specific antigen levels in the absence of prostate cancer in Middle-Eastern men: the clinician's dilemma.
    Kehinde EO; Sheikh M; Mojimoniyi OA; Francis I; Anim JT; Nkansa-Dwamena D; Al-Awadi KA
    BJU Int; 2003 May; 91(7):618-22. PubMed ID: 12699471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of NIH-IV prostatitis on free and free-to-total PSA.
    Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
    Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chronic prostatitis on angiogenic activity and serum prostate specific antigen level in benign prostatic hyperplasia.
    Koseoglu RD; Erdemir F; Parlaktas BS; Filiz NO; Uluocak N; Etikan I
    Kaohsiung J Med Sci; 2007 Aug; 23(8):387-94. PubMed ID: 17666305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Association between Prostate-Specific Antigen Velocity (PSAV), Value and Acceleration, and of the Free PSA/Total PSA Index or Ratio, with Prostate Conditions.
    Flores-Fraile MC; Padilla-Fernández BY; Valverde-Martínez S; Marquez-Sanchez M; García-Cenador MB; Lorenzo-Gómez MF; Flores-Fraile J
    J Clin Med; 2020 Oct; 9(11):. PubMed ID: 33114134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PSA in prostatic fluid].
    Lehmann K; Simmler F; Schmucki O; Hauri D
    Urologe A; 1994 May; 33(3):232-4. PubMed ID: 7519804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
    Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
    Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
    Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
    J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
    Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
    Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
    Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
    Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features of benign prostatic hyperplasia complicated by chronic prostatitis].
    Chang DG; Li GS; Zhang PH; Wu TL; Mei XF; Cao J; Gao P
    Zhonghua Nan Ke Xue; 2010 Sep; 16(9):830-3. PubMed ID: 21171270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.
    Freitas D; Andriole GL; Freedland SJ; Neto BS; Moreira DM
    Urology; 2019 Jul; 129():160-164. PubMed ID: 30914334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
    Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
    Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of histological prostatitis and its correlation with PSA density.
    Piovesan AC; Freire Gde C; Torricelli FC; Cordeiro P; Yamada R; Srougi M
    Clinics (Sao Paulo); 2009; 64(11):1049-51. PubMed ID: 19936177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.